2020 Controlled & Modified Drug Release Summit (San Diego, CA, United States – August 31, 2020 – September 2, 2020) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “2020 Controlled & Modified Drug Release Summit” conference has been added to ResearchAndMarkets.com’s offering.

Gather insights into the latest technologies and methods in improving drug release mechanisms, maximizing exposure, and reducing time-to-market.

Now in its 7th successful year and on course to be the biggest yet, our popular 2020 Controlled & Modified Drug Release Summit gives you unprecedented access to 50+ of the industry’s leading drug development & delivery experts. Attend and learn from multiple specially curated and unique case study sessions that give you actionable take-home examples to enhance your drug product pipeline. Gather insights into the latest technologies and methods for improving drug release mechanisms, maximizing exposure, and reducing time-to-market. Additionally, this must-attend event will showcase the latest regulatory guidance updates and the implications for the industry.

This intensive 3-Day program will share innovative controlled and modified drug release strategies that will benefit your current and future product pipelines. Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel controlled and modified release strategies, which could speed up time to market and save your organization millions. Can you afford to miss this?

You Will Learn

• Precision medicine & healthcare delivery: making precision medicine a reality via novel technology advancements
• Regulatory guidance for modified release dosage forms
• Advances in ocular delivery
• Micro and nanoparticle delivery
• Parenteral routes of administration
• Topical and transdermal delivery
• Oral peptide commercialization and delivery
• Enhancing patient adherence via drug delivery
• Oral drug formulation and delivery technologies

Improve The Performance Of Your Drug Products

Meet 160+ drug development professionals & learn over 2 YEARS worth of new product development strategies, formulation approaches, delivery technologies & regulatory updates while decreasing drug product time-to-market in just 3 days!

Speakers

Tycho Heimbach, PhD

Director, PK Sciences, PBPK and Biopharmaceutics, Novartis

Rakesh Dixit, PhD

Vice President, R&D, Head Biologics Safety Assessment, AstraZeneca

Mohammad Al-Sayah, PhD

Senior Scientist, Drug Product Development, Genentech Inc.

Eric Munson, PhD

Head, Department of Industrial and Physical Pharmacy, Purdue University

Yingkai Liang, PhD

Senior Scientist, Discovery Pharmaceutical Sciences, Merck & Co.

Jae Yoo, PhD

Chief Technology Officer, Aprecia Pharmaceuticals

Scott Shandler, PhD

Founder and CEO, Longevity Biotech

Vincent Ling, PhD

Senior Director, Advanced Technologies, Drug Product Development, Takeda

Di Bei, PhD

Senior Clinical Pharmacologist, Bristol-Myers Squibb

Victor Hruby, PhD

Regents Professor, Department of Chemistry, University of Arizona

Umar Maharoof, PhD

Associate Director, Dosage Form Development, Medimmune

Xiaoling Li, PhD

Associate Dean and Professor, University of the Pacific

John Lambris, PhD

Dr. Ralph and Sallie Weaver Professor of Research Medicine, University of Pennsylvania

Biplop Mitra, PhD

Principal Research Scientist, Drug Product Development, Celgene Corporation

Daniel Skomski, PhD

Senior Scientist, Merck

Shirlynn Chen, PhD

Distinguished Research Fellow, Boehringer Ingelheim

For more information about this conference visit https://www.researchandmarkets.com/r/ren1pj

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900